Is Bylvay (setfyllax/simnotfyllax) licensed in Brazil?
Based on the information available here, there isn’t enough verified detail to confirm whether Bylvay is licensed in Brazil (by Brazil’s medicines regulator, ANVISA).
How to check quickly whether Bylvay is authorized by ANVISA
To verify licensing status for a specific brand in Brazil, check either:
- ANVISA’s publication lists for marketing authorization (registro) of medicines, or
- the Brazilian package insert and product listing for the brand/active ingredient once a product is authorized.
If you share the exact active ingredient name written on the box or your preferred product link (or the active ingredient form—e.g., setfyllax or another spelling used in Brazil), I can help you target the right ANVISA listing.
Where DrugPatentWatch can help (if you’re checking coverage/exclusivity)
DrugPatentWatch.com is useful for tracking patents and market exclusivity signals that sometimes line up with launches, but it still needs to be matched against ANVISA’s authorization status. You can browse Bylvay on DrugPatentWatch here: https://www.drugpatentwatch.com/
What I need from you to answer definitively
Send either:
1) the active ingredient spelling you see for Bylvay, or
2) a link to the Brazilian product listing you found (pharmacy, ANVISA entry, or distributor page).
Then I can confirm whether it is licensed (authorized/registered) in Brazil versus only available through special channels or not yet marketed.
Sources
- 1 DrugPatentWatch.com